Grifols Establishes Expert Advisory Council in Transfusion Medicine

BARCELONA, Spain, March 7, 2011 - Grifols, a global healthcare company and biopharmaceutical manufacturer
based in Barcelona, Spain today announced that it has established an Expert
Advisory Council in Transfusion Medicine drawing on the expertise of
internationally renowned physicians and researchers from across the globe.
The role of the Expert Advisory Council is to provide insight, advice and
guidance to Grifols' own transfusion medicine research and development
activities.

(Logo: photos.prnewswire.com/prnh/20110304/PH59473LOGO )

"Bringing together these leaders in transfusion medicine underscores our
longstanding commitment to being a world leader in blood diagnostics and
transfusion medicine," said Eva Bastida, Ph.D, Scientific Director of
Grifols. "Working with this team of experts will bring new perspectives to
shape our strategic goals and plans," continued Dr. Bastida. Grifols
Diagnostics is focused on the development of cutting-edge technologies for
use in clinical laboratories and blood banks.

"It is an honor to serve with my transfusion medicine colleagues on the
Grifols Expert Advisory Council," said Mr. John Moulds, MT (ASCP) director of
Scientific Support Services at LifeShare Blood Centers, Shreveport, Louisiana
who serves as the Council Chair. "Working with such a highly esteemed group
of thought leaders will no doubt bear fruit that will help shape future
directions in transfusion medicine," stated Mr. Moulds.

Grifols has a seventy-year history of advancing blood diagnostics and
transfusion medicine remains a core part of its business today. With input
from the Expert Advisory Council Grifols will continue to advance its mission
of improving hemovigilance, transfusion safety, and the quality of life for
people who receive blood transfusions. The broad geographic diversity of
Advisory Council members is expected to stimulate creative new approaches to
current transfusion medicine challenges.

Grifols portfolio of products and services cover every link of the
transfusion chain: blood bags and donation kits, blood component separators,
autoanalyzers and reagents for pre-transfusion analytical tests (blood typing
and donor-recipient compatibility studies) and blood bank management
software, among others.

Members of the Advisory Council

The Advisory Council is chaired by Mr. John Moulds, MT (ASCP) director of
Scientific Support Services at LifeShare Blood Centers, Shreveport,
Louisiana, USA, and its membership consists of nine globally respected
experts from different countries. Members of the Grifols Advisory Council on
Transfusion Medicine include:

    Dr. Jill R. Storry, Ph.D.
    Docent / Assoc. Professor
    KIT / Clinical Immunology and Transfusion Medicine
    Labmedicin Skane University
    and Regional Laboratories Lund - SWEDEN

    Prof. Dr. Lilian Castilho, PhD
    Coordinator, Blood Center of Campinas
    CEP Campinas SP - BRAZIL

    Dr. Miquel Lozano, MD, PhD
    Chief of the Hemotherapy Section of the Department of Hemotherapy and
    Hemostasis, Hospital Clinic of Barcelona,
    Barcelona, Spain.

    Dr. Arthur Bracey, MD
    Medical Director, Transfusion Services
    St. Luke's Episcopal Hospital
    Houston, TX - US

    Prof. W. John Judd, FIBMS, MIBiol
    President and CEO
    Immunohematology Consulting, LLC
    Supply, NC - US

    Dr. Mark Yazer, MD FRCPC
    Associate Professor of Pathology, University of Pittsburgh
    Medical Director, RBC Serology Reference Laboratory, Centralized
    Transfusion Service, The Institute for Transfusion Medicine
    Pittsburgh, PA US

    Dr. Yoshihiko Tani, MD, PhD
    Japanese Red Cross
    Osaka Blood Center - JAPAN

    Prof. Neil Avent
    Head of School
    School of Biomedical and Biological Sciences
    University of Plymouth, Plymouth, UK

    Dr. Jacques Chiaroni
    Directeur de l'Etablissement Francais du Sang Alpes-Mediterranee
    Marseille, FRANCE

About Grifols

Grifols is a Spanish holding company, specializing in the
hospital-pharmaceutical sector, and with a presence in over 90 countries.
Since May 2006 Grifols has been listed on the Spanish Continuous Market, and
has been included in the Ibex-35 since 2008. Grifols focuses on the research,
development, manufacture and marketing of plasma products, diagnostic
systems, intravenous therapies, enteral nutrition and medical supplies. In
recent years Grifols has made significant investments in the area of
transfusion medicine to advance its mission of improving hemovigilance,
transfusion safety, and the quality of life for people who receive blood
transfusions. For more information visit www.grifols.com.

Chris Healey, +1-703-351-5004